Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 5

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 5
---
bett as Chief Business Officer in January 2025. Both executives are strengthening our business progression and initial execution of the 5x30 plan to grow our base commercial business and advance a robust pipeline. As part of the Board’s ongoing refreshment, two independent directors, former Chair Paul Hastings and Andreas Wicki, retired in January 2025. We thank both Paul and Andreas for their invaluable contributions to the Board over the past two decades. Our Board is composed of highly qualified leaders who are committed to supporting Pacira’s mission and contribute expertise in skills critical to the oversight of Pacira’s execution of strategy, including R&D, M&A, human capital management, operations and finance. We are pleased to prioritize an active and ongoing refreshment process which has resulted in the appointment of four new independent directors in the past two years. We appreciated the opportunity to engage with our stockholders and the Board continues to value open and transparent dialogue as we believe regular engagement allows us to better understand investor perspectives and viewpoints, ultimately enabling us to effectively shape our governance priorities and protect and represent our stockholders’ interests. The Board remains confident in the strength of Pacira’s strategic priorities and the current leadership team’s ability to drive growth in markets of unmet need and to create value for all of our stakeholders. On behalf of the entire Board of Directors, we thank you for your support. Sincerely, Independent Board Chair

TABLE OF CONTENTS

VOTING MAP

| 1                                                                                                                                                                                                                                                                                                                                                                                                                              | ​ | ​ | Election of Directors | ​ | ​ | ​ | ​ | ​ |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 4 | ​ | ​ | Advisory Vote on the Frequency ofFuture Advisory Votes to ApproveExecutive Compensation | ​ |
| The board of directors and the Nominating, Governance and Sustainability Committee believe that the three nominees for election as a Class II director (Marcelo Bigal, Frank D. Lee, and Alethia Young) to serve until the 2028 annual meeting of stockholders possess the necessary qualifications, experience, and skills to serve as directors and help advance the long-term value creation interests of all stockholders. 
 Board Recommendation:FOReachnominee                                                                                                                                                                                                                                                                                                                                                                                            
 See page16for more information.                                                                                                                                                                                                                                                                                                                                                                                                |   |   |                       | ​ | ​ | ​ | ​ | ​ | Stockholders are being provided the opportunity to vote on how often they believe the Company should hold an advisory vote to approve executive compensation in the future. The frequency options are to hold the advisory vote to